HR 5597
111th Congress
House
Health
Cancer
Drug therapy
Government studies and investigations
Health technology, devices, supplies
Hereditary and development disorders
Home and outpatient care
Immunology and vaccination
Medicare
To establish a Medicare patient IVIG access demonstration project.
Introduced: June 24, 2010
Introduced by:
Matsui, Doris O.
Democratic
· California
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 24, 2010
Referred to House Energy and Commerce
Jun 24, 2010
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 24, 2010
Referred to House Ways and Means
Jun 24, 2010
Introduced in House
Plain-English summary
Directs the Secretary of Health and Human Services (HHS) to establish a demonstration project under title XVIII (Medicare) of the Social Security Act (SSA) to evaluate the benefits of providing payment for items and services needed for the administration, within the homes of Medicare beneficiaries, of intravenous immune globin (IVIG) for the treatment of primary immune deficiency diseases.
Amends SSA title XVIII to treat as durable medical equipment (DME) any disposable drug delivery systems, including elastomeric infusion pumps, for the treatment of colorectal cancer.
What's happening now
Referred to House Energy and Commerce
Committees of jurisdiction
2